DELAYED-RELEASE DIMETHYL FUMARATE-ASSOCIATED LYMPHOPENIA

被引：0
|
作者：
Chan, Andrew [1 ]
Fox, Robert J. [2 ]
Bar-Or, Amit [3 ,4 ]
Chen, Chongshu [5 ]
Fam, Sami [5 ]
Gold, Ralf [1 ]
Hanna, Jerome [5 ]
Mehta, Devangi [5 ]
Phillips, J. Theodore [6 ]
机构：
[1] Univ Bern, Bern Univ Hosp, Inselspital, Bern, Switzerland
[2] Cleveland Clin, Mellen Ctr Multiple Sclerosis Treatment & Res, Cleveland, OH 44106 USA
[3] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
[4] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
[5] Biogen, Cambridge, MA USA
[6] Baylor Inst Immunol Res, Dallas, TX USA
来源：
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 2019年 / 90卷 / 12期
关键词：
D O I：
10.1136/jnnp-2019-ABN-2.146
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
159
引用
收藏
页码：E53 / E53
页数：1
相关论文
共 50 条
  • [1] Delayed-release dimethyl fumarate-associated lymphopenia: on-treatment and post-treatment implications
    Chan, A.
    Foxe, R. J.
    Bar-Or, A.
    Chen, C.
    Fam, S.
    Gold, R.
    Hannan, J.
    Mehta, D.
    Phillips, J. T.
    Yang, L.
    Miller, C.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 505 - 505
  • [2] Delayed-release Dimethyl Fumarate-associated Lymphopenia: On-treatment and Post-treatment Implications
    Chan, Andrew
    Fox, Robert J.
    Bar-Or, Amit
    Chen, Chongshu
    Fam, Sami
    Gold, Ralf
    Hanna, Jerome
    Mehta, Devanghi
    Phillips, J. Theodore
    Yang, Lili
    Miller, Catherine
    NEUROLOGY, 2019, 92 (15)
  • [3] Among Real-world Multiple Sclerosis Patients That Experience Delayed-release Dimethyl Fumarate-associated Lymphopenia, Meaningful Lymphocyte Reconstitution Occurs Approximately 3 Months After Discontinuation of Delayed-release Dimethyl Fumarate
    Rose, John
    Alvarez, Enrique
    Okuda, Darin
    Gudesblatt, Mark
    Riser, Emily
    Spelman, Timothy
    Fam, Sami
    Riester, Katherine
    Wu, Fan
    Miller, Catherine
    Butzkueven, Helmut
    NEUROLOGY, 2019, 92 (15)
  • [4] Among real-world multiple sclerosis patients that experience delayed-release dimethyl fumarate-associated lymphopenia, meaningful lymphocyte reconstitution occurs within 3 months after discontinuation of delayed-release dimethyl fumarate
    Rose, J.
    Alvarez, E.
    Okuda, D.
    Gudesblatt, M.
    Riser, E.
    Spelman, T.
    Butzkueven, H.
    Fam, S.
    Riester, K.
    Wu, F.
    Miller, C.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 678 - 679
  • [5] Patient coaching to optimize management of delayed-release dimethyl fumarate-associated gastrointestinal events and flushing: five years of experience
    Niemczyk, G.
    Begus-Nahrmann, Y.
    Rolfes, S.
    Rosenstroem, H.
    Grundler, M. -T.
    Maeurer, M.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 612 - 612
  • [6] Dimethyl Fumarate-Associated Enterocolitis
    Bajwa, Numra A.
    Bajwa, Azka A.
    Ghazala, Seham
    Masood, Umair
    AMERICAN JOURNAL OF THERAPEUTICS, 2024, 31 (04) : e448 - e450
  • [7] Dimethyl fumarate-associated PML
    Reactions Weekly, 2015, 1551 (1) : 1 - 1
  • [8] Diroximel Fumarate-associated Lymphopenia in Multiple Sclerosis
    Baek, W. S.
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 93 - 94
  • [9] Lymphocyte Decline and Reconstitution After Discontinuation in Patients With Severe, Prolonged Lymphopenia Treated With Delayed-Release Dimethyl Fumarate
    Fox, Robert J.
    Chan, Andrew
    Gold, Ralf
    Phillips, J. Theodore
    Yang, Lili
    Liu, Shifang
    Chalkias, Spyros
    Mehta, Devangi
    Taylor, Catherine
    NEUROLOGY, 2018, 90
  • [10] Lymphocyte decline and reconstitution after discontinuation in patients with severe, prolonged lymphopenia treated with delayed-release dimethyl fumarate
    Fox, R. J.
    Chan, A.
    Gold, R.
    Phillips, J. T.
    Yang, L.
    Liu, S.
    Chalkias, S.
    Mehta, D.
    Taylor, C.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 371 - 371
12345